SooHo Yeo | Medicinal Chemistry | Best Researcher Award

Published on by Academic Awards

Dr. SooHo Yeo | Medicinal Chemistry | Best Researcher Award

Research Professor from Yonsei University College of Pharmacy | South Korea

Dr. SooHo Yeo is a distinguished pharmaceutical researcher specializing in pharmaceutics, nanomedicine, and photodynamic cancer therapy. He earned his M.S./Ph.D. from the College of Pharmacy at Chung-Ang University, Seoul, Korea, with a dissertation focused on artificial skin formulation for the topical delivery of adenosine. Currently serving as a Research Professor at Yonsei University, he previously held a similar position at INJE University’s Department of Nanoscience and Engineering. Dr. Yeo’s expertise spans nano/micro-particle drug delivery, solid lipid nanoparticles, liposomes, and cosmetic dermatology. His work includes in vitro toxicology, pharmacokinetic/pharmacodynamic analysis, and OECD-guideline-based skin testing. He has published extensively in top-tier journals such as ACS Omega, Scientific Reports, International Journal of Pharmaceutics, and Pharmaceutics, with research focused on enhancing anticancer efficacy through innovative nanoparticle systems. Dr. Yeo is widely recognized for his interdisciplinary contributions that merge pharmaceutical sciences, biomedical engineering, and clinical research.

Publication Profile

Orcid

Academic Background

Dr. SooHo Yeo earned his M.S./Ph.D. degree from the prestigious College of Pharmacy at Chung-Ang University, located in Seoul, Korea. His academic journey reflects a strong foundation in pharmaceutical sciences, with a focus on drug delivery systems and dermal formulations. His doctoral research, titled “Artificial Skin Formulation for Topical Delivery of Adenosine,” showcases his early commitment to developing innovative therapeutic approaches using transdermal delivery platforms. The dissertation centered on the design and optimization of artificial skin systems to enhance the bioavailability and therapeutic impact of adenosine, a bioactive compound with potential in cosmetic and pharmaceutical applications. This research not only demonstrated Dr. Yeo’s technical expertise in pharmaceutics and cosmeceutics but also laid the groundwork for his later contributions to nanomedicine and photodynamic therapy. His education at Chung-Ang University provided a solid interdisciplinary foundation that continues to shape his impactful research in pharmaceutical innovation.

Professional Experience

Dr. SooHo Yeo has held prominent research positions that underscore his expertise in pharmaceutical sciences and nanotechnology. he has been serving as a Research Professor at the College of Pharmacy, Yonsei University, Incheon, Korea, where he contributes to cutting-edge research in drug delivery systems, photodynamic therapy, and cosmetic formulation development. Prior to this role, Dr. Yeo worked as a Research Professor in the Department of Nanoscience and Engineering at INJE University in Gimhae, Korea. During his tenure at INJE University, he focused on advanced nanomaterials for biomedical applications, integrating nanoscience with pharmacological innovation. His work at both institutions reflects a consistent dedication to interdisciplinary research, bridging pharmaceutical development with nanotechnology and bioengineering. Dr. Yeo’s professional experience highlights his active role in advancing therapeutic strategies through nanomedicine and solidifies his reputation as a leading figure in pharmaceutical and cosmetic research in South Korea.

Research Focus

Dr. SooHo Yeo’s research is firmly rooted in pharmaceutical sciences, with a specialized focus on nanomedicine, drug delivery systems, and photodynamic therapy for cancer treatment. His work centers on the development of advanced nanoformulations such as solid lipid nanoparticles, nanostructured lipid carriers, and lipid-based vesicles to enhance the therapeutic efficacy of anti-cancer agents like purpurin derivatives, doxorubicin, aspirin, and curcumin. A major theme in his research is topical and transdermal delivery systems using biocompatible polymers like hydroxypropyl methylcellulose for treating skin cancer. He also explores emulsion gels, pH-responsive nanocarriers, and cosmeceutical applications to treat or prevent conditions like postoperative adhesions and dermatological issues. His studies include in vitro and in vivo evaluations, highlighting a strong translational approach. Through consistent contributions to peer-reviewed journals, Dr. Yeo has positioned himself at the forefront of targeted drug delivery, phototherapy, and pharmaceutical nanotechnology aimed at improving patient outcomes in oncology and dermatology.

Publication Top Notes

  • Preparation and evaluation of hydroxypropyl methylcellulose‐based film incorporated with aspirin‐loaded solid lipid nanoparticles to treat skin cancer
    Year: 2025

  • Development of nanostructured lipid carriers loaded with purpurin-18 N propargylimide methyl ester to improve photodynamic therapy
    Year: 2025

  • Application of PLGA nanoparticles to photodynamic cancer therapy by encapsulating Purpurin-18-N-hydroxylimide methyl ester
    Year: 2025

  • A Celecoxib-Loaded Emulsion Gel for Enhanced Drug Delivery and Prevention of Postoperative Adhesion
    Year: 2025

  • Encapsulation of synthesized purpurin-18-N-aminoimide methyl ester in lipid nanovesicles for use as agents in photodynamic cancer therapy
    Year: 2025

Conclusion

Dr. SooHo Yeo is a highly qualified candidate for the Research for Best Researcher Award. His cutting-edge work in nanoparticle-based drug delivery systems, photodynamic therapy, and cosmeceutical formulations, combined with an impressive publication record and solid research positions, positions him as a frontrunner in pharmaceutical sciences. While metrics on citations and translational outcomes could further bolster his candidacy, his depth of expertise, innovation, and interdisciplinary application make him strongly suitable for this award.

 

Fidel Ernesto Morales Vicente | Antimicrobial Peptides | Best Researcher Award

Published on by Academic Awards

Dr. Fidel Ernesto Morales Vicente | Antimicrobial Peptides | Best Researcher Award

Research Associate at Center for Genetic Engineering and Biotechnology, Cuba

🧪 Dr. Fidel Ernesto Morales Vicente is an Auxiliary Researcher at the Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba. He holds a Ph.D. in Chemistry from the Federal University of São Carlos, Brazil, specializing in covalent modifications of antimicrobial and anticancer peptides. With expertise in peptide synthesis, bioorganic chemistry, and biomedical research, he has led multiple research projects and industry collaborations. Dr. Morales has also served as a Teaching Assistant Professor at the University of Havana. His contributions advance therapeutic peptide development and organic synthesis.

Publication Profile

Google Scholar

🎓 Education & Qualifications

Dr. Fidel Ernesto Morales Vicente is a distinguished chemist with a strong academic background. He earned his Ph.D. in Chemistry from the Federal University of São Carlos, Brazil, focusing on covalent modifications of antimicrobial and anticancer peptides 🧪. His Ph.D. was later homologated at the University of Havana, Cuba. He holds a Master’s in Chemistry (2014) and a Bachelor’s in Chemistry (2012) from the University of Havana, graduating with a Gold Diploma 🏅. Dr. Morales has also been part of Cuba’s national preselection team for International Chemistry Olympiads 🏆, demonstrating excellence in organic synthesis and peptide chemistry.

 

👨‍🔬 Professional Experience

Dr. Fidel Ernesto Morales Vicente is an Auxiliary Researcher at the Peptide Synthetic Group, Center for Genetic Engineering and Biotechnology (CIGB), Havana 🧪. Previously, he served as a Research & Development Specialist at CIGB and led the Biomedical Research Group at the University of Havana 🏥. He played a key role in a Company-University Agreement on therapeutic peptide modifications. Dr. Morales has extensive teaching experience as a Teaching Assistant Professor at the University of Havana 🎓. His expertise spans organic synthesis, peptide chemistry, and biomedical research, contributing significantly to scientific advancements in Cuba and Brazil.

 

🏆 Awards and Honors

Dr. Fidel Ernesto Morales Vicente has received multiple prestigious awards for his contributions to chemistry and biomedical research 🎖️. In 2024, he won the Havana University Prize for his work on antifungal peptides 🦠. He was honored with the CITMA Young Researcher Award in 2023 and the Special CITMA Award (2022) for his role in developing the Abdala COVID-19 vaccine 💉. His earlier accolades include the Cuban Academy of Science Prize (2016) and multiple Havana University Research Prizes. As a student, he earned Olympiad medals 🏅, including a Bronze Medal at the Iberoamerican Olympiad (2006).

 

🎓 Teaching Experience

Dr. Fidel Ernesto Morales Vicente has extensive teaching experience in chemistry and peptide synthesis 🧪. In 2023, he delivered a postgraduate course on Solid Phase Peptide Synthesis for the Master’s in Biotechnology at the Center for Genetic Engineering and Biotechnology, Havana 🏫. He previously supervised teaching internships at the Federal University of São Carlos, Brazil (2018) and taught the Chemical Reaction postgraduate course (2017). From 2012 to 2020, he lectured and assisted in General Chemistry courses at the University of Havana, guiding students in biochemistry, microbiology, and physical engineering 📚.

 

🔬 Research Focus

Dr. Fidel Ernesto Morales Vicente specializes in peptide chemistry, antimicrobial peptides, and bioorganic synthesis 🧪. His research explores macrocyclization, multicomponent reactions, and peptide modifications for drug discovery 💊. He has contributed significantly to antifungal and antibacterial peptides, particularly Cm-p5 derivatives, targeting Candida auris and biofilm-related infections 🦠. His expertise extends to peptide organocatalysis, peptide-steroid conjugation, and solid-phase peptide synthesis 🔬. He also investigates peptide-lipid interactions, antifungal mechanisms, and peptide-based drug delivery. His work bridges synthetic chemistry, biotechnology, and pharmacology, making key advancements in therapeutic peptide development ⚕️.

 

Publication Top Notes

1️⃣ Macrocyclization of Peptide Side Chains by the Ugi Reaction | J. Org. Chem. | 📖 65 citations | 📅 2015
2️⃣ A Multiple Multicomponent Approach to Chimeric Peptide–Peptoid Podands | Chem.–Eur. J. | 📖 63 citations | 📅 2013
3️⃣ Aminocatalysis-Mediated on-Resin Ugi Reactions | Org. Lett. | 📖 47 citations | 📅 2015
4️⃣ Bidirectional Macrocyclization of Peptides | Org. Biomol. Chem. | 📖 40 citations | 📅 2015
5️⃣ Helical-Stabilized, Cyclic Peptide Cm-p5 with Antifungal Activity | ACS Omega | 📖 36 citations | 📅 2019
6️⃣ Cm-p5 Peptide Derivatives Inhibit Candida auris Biofilms | Antibiotics | 📖 33 citations | 📅 2020
7️⃣ CuI-Catalyzed Alkyne–Azide Cycloaddition in Peptide Conjugation | Tetrahedron | 📖 27 citations | 📅 2014
8️⃣ New Antibacterial Peptides from Freshwater Mollusk Pomacea poeyana | Biomolecules | 📖 26 citations | 📅 2020
9️⃣ Antimicrobial Peptides: Therapeutic Potential | Rev. Cubana Med. Trop. | 📖 17 citations | 📅 2017
🔟 Pom-1 and Pom-2 Peptides Active Against Candida Biofilms | Pathogens | 📖 16 citations | 📅 2021